IDEAYA Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC IDYA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

174,124

Value ($000)

6,019

Weight

0.0%

2021 Q4 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	6,019	0.0%	174,124	12/31/2025
2025 Q3	11/14/2025	5,481	0.0%	201,443	9/30/2025
2025 Q2	8/14/2025	5,731	0.0%	272,660	6/30/2025
2025 Q1	5/19/2025	4,966	0.0%	303,145	3/31/2025
2024 Q4	2/14/2025	8,308	0.0%	323,286	12/31/2024
2024 Q3	11/14/2024	10,090	0.0%	318,496	9/30/2024
2024 Q2	8/14/2024	10,964	0.0%	312,277	6/30/2024
2024 Q1	5/15/2024	10,159	0.0%	231,518	3/31/2024
2023 Q4	2/14/2024	9,753	0.0%	274,101	12/31/2023
2023 Q3	11/13/2023	7,295	0.0%	270,391	9/30/2023
2022 Q4	2/14/2023	583	0.0%	32,072	12/31/2022
2022 Q3	11/14/2022	225	0.0%	15,073	9/30/2022
2022 Q2	8/12/2022	139	0.0%	10,100	6/30/2022
2022 Q1	5/16/2022	113	0.0%	10,100	3/31/2022
2021 Q4	2/14/2022	239	0.0%	10,100	12/31/2021